Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel https://t.co/EWtTP4qwgg
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
RT @doctorpemm: #IACH19 Great teaching slides from Professor Falini on #NPM1-mutated AML & for context full 2017 ELN AML risk stratificatio…
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel https://t.co/Z4ilmYiVcK
New Guidelines: Diagnosis and management of #AML in adults: 2017 ELN recommendations from an international expert panel. - PubMed - NCBI https://t.co/Pjrtcj5CTu
RT @SaudiLeukemia: AML Reminder: Alternate day HIDAC (days 1,3,5) no longer a recommended consolidation in ELN 2017. No more 2-3g/m2 of Ara…
RT @SaudiLeukemia: AML Reminder: Alternate day HIDAC (days 1,3,5) no longer a recommended consolidation in ELN 2017. No more 2-3g/m2 of Ara…
RT @SaudiLeukemia: AML Reminder: Alternate day HIDAC (days 1,3,5) no longer a recommended consolidation in ELN 2017. No more 2-3g/m2 of Ara…
RT @SaudiLeukemia: AML Reminder: Alternate day HIDAC (days 1,3,5) no longer a recommended consolidation in ELN 2017. No more 2-3g/m2 of Ara…
AML Reminder: Alternate day HIDAC (days 1,3,5) no longer a recommended consolidation in ELN 2017. No more 2-3g/m2 of AraC. Either 1-1.5g/m2 q12hrly on day 1-3 , or 1-1.5g/m2 daily for 5-6 days. Just as effective as CALGB regimen, and safer! https://t.co/
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @DrMiguelPerales: Diagnosis and management of AML in adults: 2017 ELN recommendations @BloodJournal #EHA22 #leusm https://t.co/vVnmLeCH…
RT @DrMiguelPerales: Diagnosis and management of AML in adults: 2017 ELN recommendations @BloodJournal #EHA22 #leusm https://t.co/vVnmLeCH…
Diagnosis and management of AML in adults: 2017 ELN recommendations @BloodJournal #EHA22 #leusm https://t.co/vVnmLeCH58
See full paper on ELN2017 recommendations in AML here: https://t.co/grdjGFInee
Diagnosis and management of AML in adults: 2017 ELN recommendations international expert panel https://t.co/ccneylSyi4
RT @mtsanchez25: #ebmt17 Leukemia Net 2017 recommendations for AML diagnosis and treatment https://t.co/Lyqy1SEGJW
#ebmt17 Leukemia Net 2017 recommendations for AML diagnosis and treatment https://t.co/Lyqy1SEGJW
RT @evemariecrane: T3: 2017 ELN adult leukemia guidelines emphasize need to also check for FLT3 point mutations and ASXL1 #pathJC https://t…
RT @evemariecrane: T3: 2017 ELN adult leukemia guidelines emphasize need to also check for FLT3 point mutations and ASXL1 #pathJC https://t…
RT @evemariecrane: T3: 2017 ELN adult leukemia guidelines emphasize need to also check for FLT3 point mutations and ASXL1 #pathJC https://t…
RT @evemariecrane: T3: 2017 ELN adult leukemia guidelines emphasize need to also check for FLT3 point mutations and ASXL1 #pathJC https://t…
RT @evemariecrane: T3: 2017 ELN adult leukemia guidelines emphasize need to also check for FLT3 point mutations and ASXL1 #pathJC https://t…
T3: 2017 ELN adult leukemia guidelines emphasize need to also check for FLT3 point mutations and ASXL1 #pathJC https://t.co/PyzNZc16p6
@zapata_nidia, básicamente mucho avance en el diagnóstico, poco en el tratamiento 😔 https://t.co/v4doF85ZD2
RT @dianis_nm: Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel https://t.co/8IX5BvQ3…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @caner_saygin: 2017 ELN stratification: RUNX1, ASXL1, and TP53 mutated AML are formally categorized as adverse risk. https://t.co/HPTCc6…
RT @caner_saygin: 2017 ELN stratification: RUNX1, ASXL1, and TP53 mutated AML are formally categorized as adverse risk. https://t.co/HPTCc6…
RT @caner_saygin: 2017 ELN stratification: RUNX1, ASXL1, and TP53 mutated AML are formally categorized as adverse risk. https://t.co/HPTCc6…
RT @caner_saygin: 2017 ELN stratification: RUNX1, ASXL1, and TP53 mutated AML are formally categorized as adverse risk. https://t.co/HPTCc6…
RT @caner_saygin: 2017 ELN stratification: RUNX1, ASXL1, and TP53 mutated AML are formally categorized as adverse risk. https://t.co/HPTCc6…
2017 ELN stratification: RUNX1, ASXL1, and TP53 mutated AML are formally categorized as adverse risk. https://t.co/HPTCc6eg5p @BloodJournal https://t.co/7JN0aXMBPg
RT @BldCancerDoc: Diagnosis and management of #AML in adults: 2017 ELN recommendations https://t.co/YMbL0QRmOt via @BloodJournal #leusm #bm…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
Diagnosis and management of AML in adults: 2017 ELN recommendations https://t.co/EEHcWrRfV0
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel https://t.co/OtqTTjD9Ot
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel https://t.co/U7cTZ08gZ7
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @SCTNB: Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood https://t.co/6zA…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @SCTNB: Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood https://t.co/6zA…
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood https://t.co/6zAU2VYioS
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
RT @BloodJournal: Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN…
Review Article: 2017 ELN recommendations for diagnosis and management of #AML https://t.co/Oj9HkM2bpK https://t.co/xiV0tN1gLc
Article fr @BloodJournal on European LeukemiaNet recommendations on diagnosis and other components of AML #hemepath https://t.co/mL0Ovu5WpX
RT @BldCancerDoc: Diagnosis and management of #AML in adults: 2017 ELN recommendations https://t.co/YMbL0QRmOt via @BloodJournal #leusm #bm…
RT @BldCancerDoc: Diagnosis and management of #AML in adults: 2017 ELN recommendations https://t.co/YMbL0QRmOt via @BloodJournal #leusm #bm…
RT @bloodworkapp: Diagnosis & management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood Journal http…
RT @raffaella_g: Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. https://t.co/fV…
RT @ymori117: Blood「成人急性骨髄性白血病の診断と治療:欧州白血病ネットワーク国際専門委員会による推奨2017」 https://t.co/GysCQuIhdz 25ページあります。知見は増えたけど、治療は結局 7+3。
Blood「成人急性骨髄性白血病の診断と治療:欧州白血病ネットワーク国際専門委員会による推奨2017」 https://t.co/GysCQuIhdz 25ページあります。知見は増えたけど、治療は結局 7+3。
RT @raffaella_g: Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. https://t.co/fV…
From Blood Journals:Diagnosis and management of AML in adults: 2017 ELN recommendations from an expert panel. https://t.co/8EyFEoLHVb
RT @BldCancerDoc: Diagnosis and management of #AML in adults: 2017 ELN recommendations https://t.co/YMbL0QRmOt via @BloodJournal #leusm #bm…
RT @BldCancerDoc: Diagnosis and management of #AML in adults: 2017 ELN recommendations https://t.co/YMbL0QRmOt via @BloodJournal #leusm #bm…
RT @BldCancerDoc: Diagnosis and management of #AML in adults: 2017 ELN recommendations https://t.co/YMbL0QRmOt via @BloodJournal #leusm #bm…
RT @bloodworkapp: Diagnosis & management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood Journal http…
RT @bloodworkapp: Diagnosis & management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood Journal http…
RT @BldCancerDoc: Diagnosis and management of #AML in adults: 2017 ELN recommendations https://t.co/YMbL0QRmOt via @BloodJournal #leusm #bm…
RT @BldCancerDoc: Diagnosis and management of #AML in adults: 2017 ELN recommendations https://t.co/YMbL0QRmOt via @BloodJournal #leusm #bm…
RT @BldCancerDoc: Diagnosis and management of #AML in adults: 2017 ELN recommendations https://t.co/YMbL0QRmOt via @BloodJournal #leusm #bm…
Diagnosis & management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood Journal https://t.co/6MNtyne9Mg
RT @raffaella_g: Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. https://t.co/fV…
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel https://t.co/SwcuKMD07l
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. https://t.co/fVu4KNxyMj
RT @BldCancerDoc: Diagnosis and management of #AML in adults: 2017 ELN recommendations https://t.co/YMbL0QRmOt via @BloodJournal #leusm #bm…
Diagnosis and management of #AML in adults: 2017 ELN recommendations https://t.co/YMbL0QRmOt via @BloodJournal #leusm #bmtsm
"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel" https://t.co/tlPo01kN6Y
RT @riadelfakih: @SaudiLeukemia @FFRAIH @KfshSct @MikkaelSekeres @Mohty_EBMT AML ELN 2017 guidelines https://t.co/vEIwjtS9Zx
@SaudiLeukemia @FFRAIH @KfshSct @MikkaelSekeres @Mohty_EBMT AML ELN 2017 guidelines https://t.co/vEIwjtS9Zx
RT @DrChrisHourigan: CR is dead. Long live CR (MRD-). Diagnosis and management of AML in adults: 2017 ELN recommendations h…
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood Journ https://t.co/fuqXOPJS2m
2017 ELN recommendations from an international expert panel on the diagnosis and management of AML in adults: https://t.co/4LbKsjw2WZ #leusm
RT @gedefo_sefh: "Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel" https://t.co/JKH9…
"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel" https://t.co/JKH9XkWpK3